RxDoctor Payments Data

Jonathan Kao, MD

Ophthalmology · Mesa, AZNPI 1295779684

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.6% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Rxsight Inc at 40.4% of the total. Reporting peaked in 2023 at $292 and has fallen 88.8% since, to $33 in 2025. That places this record below the midpoint for ophthalmology clinicians in AZ, where the typical reported total is $1,526.

$978in general payments, 2019–2025

Across 19 payments — averaging $51.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rxsight Inc$395
  • Glaukos Corporation$127
  • Dompe US, Inc.$103
  • Carl Zeiss Meditec USA, Inc.$74
  • Heidelberg Engineering, Inc.$68
  • Johnson & Johnson Surgical Vision, Inc.$56
  • plus $157 from 5 others

What the payments were for

  • Food & beverage$92595%
  • Gifts$535%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$978 in reported general payments places this provider in the 35th percentile of 310 ophthalmology providers in Arizona.

See all ophthalmology providers in Arizona →

Medicare billing

Part B allowed, 2024
$370,910
Medicare patients
736
Services billed
3,649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate434$13,535
Ketorolac Tromethamine235$4,258
Fluorometholone40$3,825
ValacyclovirValacyclovir Hcl56$3,118
Ofloxacin262$2,768
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol14$1,964
Latanoprost136$1,841
Timolol Maleate124$1,332
Tobramycin-DexamethasoneTobramycin/Dexamethasone27$1,300
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat31$677
Acyclovir15$271
Brimonidine Tartrate17$131

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Mesa

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →